NCT04088773View on ClinicalTrials.gov

Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease

Active, not recruitingOBSERVATIONAL
Enrollment

232

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

September 1, 2023

Study Completion Date

June 30, 2026

Conditions
Crohn Disease
Interventions
DIAGNOSTIC_TEST

blood biomarkers

biomarkers to distinguish fibrotic vs non-fibrotic CD lesions

DIAGNOSTIC_TEST

stool biomarkers

fecal biomarkers of inflammation, mucosal inflammation

DIAGNOSTIC_TEST

MRI imaging

MRI imaging to detect bowel wall fibrosis and to detect inflamed, non-fibrotic from inflamed, fibrotic bowel

Trial Locations (4)

30322

Emory/Children's Healthcare of Atlanta, Atlanta

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

48109

Michigan Medicine, Ann Arbor

55905

Mayo Clinic, Rochester

All Listed Sponsors
collaborator

The Leona M. and Harry B. Helmsley Charitable Trust

OTHER

lead

Children's Hospital Medical Center, Cincinnati

OTHER